Related Experiment Videos
Structural studies with the uveopathogenic peptide M derived from retinal S-antigen
A Muga1, W K Surewicz, P T Wong
1Division of Chemistry, National Research Council of Canada, Ottawa.
Biochemistry
|March 27, 1990
Summary
Bovine S-antigen peptide M forms beta-sheet assemblies, driving autoimmune uveitis. This structure, stabilized by salt bridges, is disrupted by pH changes or pressure, supporting a model of immunogenic peptide presentation.
Area of Science:
- Immunology
- Structural Biology
- Biochemistry
Background:
- The 18-residue fragment of bovine S-antigen (peptide M) is a potent inducer of experimental autoimmune uveitis.
- Understanding the structural basis of peptide M's immunogenicity is crucial for autoimmune disease research.
Purpose of the Study:
- To investigate the solution conformation and assembly behavior of the immunogenic bovine S-antigen peptide M.
- To elucidate the structural factors contributing to peptide M's ability to induce experimental autoimmune uveitis.
Main Methods:
- Fourier-transform infrared spectroscopy (FTIR)
- Circular dichroism (CD) spectroscopy
- Analysis of peptide assembly under varying pH and hydrostatic pressure conditions.
Main Results:
- Peptide M forms stable macromolecular assemblies with intermolecular beta-sheet structures between pH 4 and 9.5.
- These beta-sheet assemblies are stabilized by ionic interactions (salt bridges) between carboxylate and basic residues.
- Disruption of salt bridges via pH changes (below 4 or above 9.5) or elevated hydrostatic pressure destabilizes the assemblies.
- Under conditions favoring monomers, peptide M exhibits a mixed secondary structure of unordered elements and beta-sheets.
Conclusions:
- The formation of intermolecular beta-sheet structures is a key feature of peptide M's behavior in solution.
- Ionic interactions play a critical role in stabilizing these immunogenic peptide assemblies.
- The findings support a model where immunogenic peptides adopt extended beta-type conformations for presentation by MHC molecules to T-cell receptors.